Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
ALBANY, N.Y., April 20, 2017 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer, is scheduled to present at the 41st Annual Deutsche Bank Health Care Conference on Thursday, May 4, 2017, at 10:00 a.m. ET. The conference will be held at the InterContinental Hotel in Boston.
A live audio and/or webcast and subsequent archived replay of AngioDynamics’ session may be accessed via the investor relations section of the Company’s website under “Events & Presentations” at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics Inc. Caitlin Stefanik (518) 795-1418 [email protected] Investor Relations Contacts: FTI Consulting Jim Polson (312) 553-6730 [email protected], Kotaro Yoshida (212) 850-5690 [email protected] Media Contact: FTI Consulting Kimberly Ha (212) 850-5612 [email protected]
